HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of chronic osteomyelitis in children resistant to previous therapy.

Abstract
Patients admitted to the authors' institution with tibial osteomyelitis between 1978 and 1998 were reviewed. The purpose of this study was to determine the incidence, etiology, treatment, and outcome in chronic pediatric tibial osteomyelitis. The authors describe their treatment of chronic osteomyelitis in children resistant to previous therapeutic modalities. Thirty patients were identified with a mean age of 8.5 years at diagnosis. Mean age at admission was 9.6 years, indicating more than a 1-year duration of disease. Follow-up averaged 2.3 years. Patients underwent 97 procedures, averaging 3.2 procedures per patient. Hospital stay ranged from 2 weeks to 18 months, with an average stay of 4.7 months. Seventy-seven percent of patients were culture-positive, and 78% of positive cultures identified Staphylococcus aureus as the causative pathogen. Eighty percent of patients had a good outcome, 13% had a fair outcome, and there were no poor results. Patients with large tibial defects obtained good results with both tibiofibular synostosis and Ilizarov distraction osteogenesis. The authors describe the only reported group of pediatric patients successfully treated using Ilizarov bone transport for bony tibial defects due to osteomyelitis.
AuthorsS Austin Yeargan 3rd, Cass K Nakasone, Mark D Shaieb, William P Montgomery, Kent A Reinker
JournalJournal of pediatric orthopedics (J Pediatr Orthop) 2004 Jan-Feb Vol. 24 Issue 1 Pg. 109-22 ISSN: 0271-6798 [Print] United States
PMID14676545 (Publication Type: Journal Article)
Topics
  • Bone Transplantation
  • Child
  • Child, Preschool
  • Chronic Disease
  • Female
  • Humans
  • Ilizarov Technique
  • Male
  • Osteomyelitis (microbiology, therapy)
  • Retrospective Studies
  • Tibia
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: